NSW Chief Justice A S Bell has indicated that members of the profession are invited to make any submissions in relation to SC Practice Note Gen 23 on the Use of Generative AI to Tipstaff Sebastian Braham:
sebastian.braham@courts.nsw.gov.au
By Thursday 18 December 2025.
[BillMaddensWordpress #2462]
The EU Commission has published its proposal for the “Digital Omnibus” aimed to simplify and streamline the EU rules governing artificial intelligence, data protection, cybersecurity, and data use more broadly. The proposal seeks to amend several cornerstone EU regulations, including Regulation (EU) 2016/679 (GDPR), Regulation (EU) 2024/1689 (AI Act), Regulation (EU) 2023/2854 (Data Act), Directive
Le 11 novembre, alors que les français célébraient l’Armistice de 1918, les juges du tribunal régional de Munich rendaient une décision importante en matière d’intelligence artificielle en condamnant Open AI pour contrefaçon de droits d’auteur.
La procédure a été initiée par la Gema, l’équivalent allemand de la SACEM, qui représente notamment les auteurs de paroles
California continues to lead the nation in artificial intelligence (“AI”) regulation with the recent enactment of Senate Bill (“SB”) 53—the Transparency in Frontier Artificial Intelligence Act (“TFAIA” or the “Act”)[1]. Signed by Governor Gavin Newsom earlier this fall, the TFAIA takes effect January 1, 2026, and establishes significant oversight, accountability, and reporting requirements
A new policy paper released on 2 November 2025 sets out the MHRA’s proposals on overhauling and transforming the UK regulation of rare therapies.
The intention is for a “bold new rulebook for rare therapies” to be published in 2026. Rare therapies is defined as medicinal products intended to treat rare diseases, specifically, conditions with a
Welcome to the latest installment of Arnold & Porter’s Virtual and Digital Health Digest. This digest covers key virtual and digital health regulatory and public policy developments during September and early October 2025 from the the United Kingdom, and European Union.
This month, the EU and UK have been actively processing the future of AI development
Healthcare organizations of every shape and size are rapidly expanding their use of artificial intelligence solutions from high-risk applications like clinical decision-support interventions, ambient listening, and charting to lower-risk administrative activities like automated patient communications and scheduling. While adoption is widespread and increasing in depth and breadth across the industry, not every healthcare organization has
Patent eligibility under 35 U.S.C. § 101 should be a straightforward threshold question: any “new and useful process, machine, manufacture, or composition of matter” is eligible for protection. Yet over time, this once-clear principle has become anything but.
Although the statute itself has remained unchanged for two centuries, its interpretation has evolved dramatically through judicial
For anyone working in the health and life sciences industries and looking to complete a few final CLE hours before the end of 2025, Reed Smith will be hosting its annual Virtual Life Sciences CLE Week, taking place from November 3 through November 7, 2025.
This week-long event will feature a series of timely and